By Counterforce Health Team in Spinraza (nusinersen) —

How to Get Spinraza (nusinersen) Covered by Cigna in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Spinraza (nusinersen) Covered by Cigna in Florida

Cigna requires prior authorization for Spinraza with genetic confirmation of SMA, neurologist prescription, and baseline motor function assessments. Submit via CoverMyMeds or fax (877-327-8413) with complete documentation. Standard review: 72 hours; expedited: 24 hours for urgent cases. If denied, file internal appeal within 180 days, then external review through Florida DFS within 4 months (free, binding if favorable).

First step today: Contact your neurologist to gather genetic testing results, SMN2 copy numbers, and baseline motor assessments (HFMSE, CHOP-INTEND, or HINE scores) needed for the PA submission.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Spinraza prescriptions Cigna PA forms portal Cigna Policy
Genetic Testing Bi-allelic SMN1 pathogenic variants confirmed Lab reports from neurologist Cigna Spinraza Policy
SMN2 Copy Number Documentation required (2-4 copies typical) Genetic testing results Cigna Policy
Neurologist Prescription Must be prescribed by SMA specialist Neurologist clinic notes FDA Requirements
Baseline Motor Assessment HFMSE, CHOP-INTEND, or HINE scores Motor function evaluation Cigna Policy
Lab Work Platelets, PT/aPTT, urine protein Pre-treatment labs Safety Requirements

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient + Clinic)

Who: Patient coordinates with neurologist's office
Documents needed: Genetic testing results, SMN2 copy numbers, baseline motor assessments, lab work
Timeline: 1-2 weeks to compile
Source: Cigna PA requirements

2. Complete Cigna Spinraza PA Form (Neurologist)

Who: Prescribing neurologist
Document: Cigna Spinraza CCRD PA form
How to submit: CoverMyMeds portal or fax 877-327-8413
Timeline: Same day submission once complete

3. Submit Complete Package (Clinic Staff)

Who: Neurologist's office staff
Contents: PA form + genetic results + motor assessments + lab work + clinical notes
Portal: Mark "urgent" if standard 72-hour review risks patient health
Expected response: 72 hours (standard) or 24 hours (expedited)

4. Track Status and Follow Up

Who: Patient or clinic
How: Call Cigna at 800-882-4462 for urgent cases
Timeline: Follow up after 3 business days if no response
Next step: If approved, enroll with Accredo specialty pharmacy (866-759-1557)

5. Handle Denial (If Needed)

Who: Patient with neurologist support
Action: File internal appeal within 180 days
Platform: myCigna portal or written submission
Enhanced evidence: Add FDA labeling, SMA guidelines, peer-reviewed studies

6. External Review (If Internal Appeal Fails)

Who: Patient
Contact: Florida Department of Financial Services at 1-877-693-5236
Timeline: Within 4 months of final internal denial
Cost: Free to consumer; binding decision if favorable

Required Documentation Checklist

Essential Documents for PA Submission

Genetic Testing Results

  • Bi-allelic SMN1 pathogenic variants confirmation
  • SMN2 copy number (attach lab report)
  • Genetic counselor or neurologist interpretation

Clinical Assessment

  • SMA type classification (I, II, III, or IV)
  • Baseline motor function using validated scale:
    • HFMSE (Hammersmith Functional Motor Scale Expanded)
    • CHOP-INTEND (Children's Hospital of Philadelphia Infant Test)
    • HINE (Hammersmith Infant Neurologic Exam)
  • Current functional status and mobility aids

Laboratory Work

  • Platelet count (PLT)
  • Prothrombin time (PT)
  • Activated partial thromboplastin time (aPTT)
  • Quantitative spot urine protein

Treatment History

  • Prior SMA treatments tried (if any)
  • Reason for not using Zolgensma (if applicable)
  • Contraindications to Evrysdi (if relevant)
Clinician Corner: When drafting the medical necessity letter, emphasize progressive motor decline, genetic confirmation of 5q SMA, and cite FDA approval for all SMA types. Reference the ENDEAR and CHERISH trial data showing significant motor improvements and include specific motor scale scores demonstrating need for intervention.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Evidence
Missing genetic confirmation Submit complete genetic testing Lab report with SMN1/SMN2 results
Inadequate motor documentation Provide validated assessment scores HFMSE, CHOP-INTEND, or HINE results
Non-specialist prescriber Transfer to neurologist Referral to SMA specialist
Prior Zolgensma use Document medical necessity Clinical notes on why Spinraza needed
Insufficient medical necessity Enhanced clinical justification FDA labeling, guidelines, trial data

Most effective appeal strategy: Include a one-page timeline of SMA progression with specific motor milestone losses and functional decline, supported by validated assessment scores.

Florida Appeals Process

Internal Appeals (Required First Step)

Timeline: File within 180 days of denial notice
Standard review: 30 days for future treatments, 60 days for rendered services
Expedited review: 72 hours for urgent cases
How to file: myCigna portal or written submission

External Review (After Internal Appeals)

When available: After exhausting internal appeals or if Cigna fails to follow proper procedures
Timeline: Request within 4 months of final internal denial
Contact: Florida Department of Financial Services at 1-877-693-5236
Cost: Free to consumer
Decision: Binding on insurer if favorable; typically within 72 hours for urgent cases

Note: Florida contracts with independent medical experts to review appeals. Success rates for specialty drug appeals can reach 50-60% when complete clinical evidence is provided.

Costs and Financial Assistance

Spinraza List Price: Approximately $118,000-$125,000 per vial
Annual Cost: $708,000-$750,000 first year; $354,000-$375,000 annually thereafter

Financial Support Options

  • Biogen Support Program: Patient assistance and copay support
  • Cigna Specialty Pharmacy: Accredo (866-759-1557) for coordination
  • Foundation Grants: Check with SMA advocacy organizations
  • State Programs: Florida may have rare disease assistance programs

For comprehensive help with prior authorization challenges, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements.

When to Escalate

Contact Florida Insurance Regulators

Florida Department of Financial Services
Consumer Services Division
Phone: 1-877-693-5236
Online: File insurance complaint

Signs You Need Regulatory Help

  • Cigna fails to respond within required timeframes
  • Improper denial without medical review
  • Violation of appeal procedures
  • Discrimination based on disability

Additional Support

  • SMA Advocacy Groups: Connect with families who've navigated similar challenges
  • Legal Assistance: Consider consulting attorneys specializing in insurance denials for rare diseases

Frequently Asked Questions

How long does Cigna PA take in Florida?
Standard review: 72 hours. Expedited review: 24 hours for urgent medical situations. Follow up after 3 business days if no response.

What if Spinraza is non-formulary on my plan?
File a formulary exception request with clinical justification. Include medical necessity documentation and evidence that formulary alternatives are inappropriate.

Can I request an expedited appeal?
Yes, if delay in treatment could seriously jeopardize health or functional ability. Document the urgency in your appeal submission.

Does step therapy apply if I've tried other SMA treatments?
Document all prior treatments and outcomes. Previous use of Evrysdi or Zolgensma doesn't automatically disqualify Spinraza if medically justified.

What happens during a peer-to-peer review?
Your neurologist discusses the case directly with Cigna's medical director. Prepare talking points on SMA progression, trial data, and why Spinraza is medically necessary.

How much will I pay out-of-pocket?
Depends on your specific Cigna plan. Specialty drugs typically have higher copays or coinsurance. Check with Accredo specialty pharmacy for cost estimates.

Can I appeal while starting treatment?
In urgent situations, you may be able to start treatment during the appeal process. Discuss with your neurologist and contact Cigna about emergency provisions.

What if I need to switch from another SMA treatment?
Document medical reasons for the switch (lack of efficacy, side effects, disease progression). Include comparative clinical data in your PA submission.

Through services like Counterforce Health, patients and clinicians can access specialized support for complex prior authorization cases, ensuring that appeals include the right evidence and are aligned with each payer's specific criteria and procedural requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and procedures may change. Always verify current requirements with Cigna and consult with your healthcare provider about treatment decisions. For assistance with insurance appeals and denials, contact the Florida Department of Financial Services or consider professional advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.